Overview of key molecular and pharmacological targets for diabetes and associated diseases
Seyed Hossein Shahcheraghi(Shahid Sadoughi University of Medical Sciences and Health Services), Murtaza M. Tambuwala(Ras al-Khaimah Medical and Health Sciences University), Pritam Kumar Panda(Uppsala University), Garima Shrivastava(Indian Institute of Technology Delhi), Abdulmajeed G. Almutary(Abu Dhabi University), Yusuf A. Haggag(Tanta University), Alaa A. A. Aljabali(Yarmouk University), Kamal Dua(University of Technology Sydney), Abdullah M. Alnuqaydan(Qassim University), Kazuo Takayama(Tokyo Medical University), Mazhar Salim Al Zoubi(Yarmouk University), Marzieh Lotfi(Shahid Sadoughi University of Medical Sciences and Health Services), Yogendra Kumar Mishra(University of Southern Denmark), Vijay Mishra(Lovely Professional University), Ángel Serrano‐Aroca(Valencia Catholic University Saint Vincent Martyr), Dinesh Kumar Chellappan(Ajman University), Debmalya Barh(Institute of Bioinformatics and Applied Biotechnology), Hamid A. Bakshi(Mayo Clinic), Gaurav Gupta(Gyan Vihar University), Nitin B. Charbe, Bojlul Bahar(University of Lancashire)
Cited by 28
Related Papers
Solid Lipid Nanoparticles: Emerging Colloidal Nano Drug Delivery Systems
|Pharmaceutics|2018|661
Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms
|Viruses|2021|450
siRNA: Mechanism of action, challenges, and therapeutic approaches
|European Journal of Pharmacology|2021|428
Functional gas sensing nanomaterials: A panoramic view
|Applied Physics Reviews|2020|410